The Recall Desk

Manufacturer

Actavis

3 recalls in our database name Actavis as the manufacturing or recalling firm.

What the numbers show

Total
3
Critical
0
Severe
1
Most recent
2014-03-05

Of the 3 recalls from Actavis we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1 (33%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–3 of 3

  • ModerateFDA (Drugs)·D-1088-2014·2014-03-05

    Actavis Recalls Subpotent Gelnique Oxybutynin Chloride Gel Samples

    Actavis is recalling Gelnique (oxybutynin chloride) Gel 10% physician samples because drug potency was compromised during shipment.

    Product
    Gelnique (oxybutynin chloride) Gel 10%, 100 mg in 1 g sachet, for topical use only. Physician sample in clamshell container with seven heat-sealed sachets. Rx Only. Watson Pharmaceuticals Inc, Corona, CA, 92890. NDC: 52544-084-77.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-599-2013·2013-06-19

    Actavis Recalls Fentanyl Transdermal Systems Due to Impurity Specifications

    Actavis is recalling Fentanyl Transdermal Systems, 50 mcg/h, because they failed impurities and degradation specifications.

    Product
    Fentanyl Transdermal System, 50 mcg/h, 1 system per pouch (NDC 0591-3212-54), packaged in 5-count systems per box (NDC 0591-3212-72), Rx only, Manufactured by Watson Laboratories, Inc, Corona, CA, 92880 USA; Distributed by: Watson Pharma, Inc.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1693-2012·2012-10-03

    Actavis Recalls Fentanyl Transdermal Systems Due to Subpotent Product

    Actavis is recalling Fentanyl Transdermal Systems, 100 mcg/h, because some patches may not contain fentanyl gel. The recall covers 98,088 cartons distributed nationwide.

    Product
    Fentanyl Transdermal System, 100 mcg/h, each transdermal system contains: 10 mg fentanyl and 0.4 mL alcohol USP, Rx only, supplied in single pouches (NDC 0591-3214-54 (pouch)), 5 pouches per carton (NDC 0591-3214-72 (Carton)), Manufactured by Watson laboratories Inc., Corona, CA,
    Category
    Drug
    Distribution
    Distributed nationwide

About this company

Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.

Actavis

pharmaceutical company

Country
Ireland
Founded
1984

Official website

Source: Wikidata (Q343204), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.